Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yedy P. Sukmawan"'
Publikováno v:
Journal of Pharmacy & Pharmacognosy Research, Vol 11, Iss 4, Pp 625-634 (2023)
Context: The essential oil of the Ageratum conyzoides (100 mg/kg BW) previously demonstrated anti-neuropathic pain activity with various mechanisms of action. However, the safety data of this essential oil is unknown. Aims: To evaluate the acute a
Externí odkaz:
https://doaj.org/article/5e5d60053c064f2a8a28a07e0bdadc53
Publikováno v:
Jurnal Farmasi Sains dan Komunitas, Vol 20, Iss 1, Pp 78-83 (2023)
The diabetic wounds are one of the global burden diseases. In our previous study, Ageratum conyzoides L. leaf ethanolic extract (purple flower type) 10%, Centella asiatica (L.) Urban leaf ethanolic extract 5%, and astaxanthin 0.1% combination gel pre
Externí odkaz:
https://doaj.org/article/a5d3bdb11f5e472caca34805675e9de7
Publikováno v:
Research Journal of Pharmacy and Technology. :140-144
The objective of the study was to determine the wound healing activity of the Clitoria ternate L. flower ethanolic extract in the gel preparation in a diabetic animal model. We conducted an optimization of the gel preparations from various concentrat
Autor:
Yedy P. Sukmawan
Publikováno v:
Indonesian Journal of Clinical Pharmacy. 9:43
Lumbrokinase has been used to treat stroke and cardiovascular disease. Fibrinogen elevation is a known risk factor and a powerful predictor of ischemic cerebrovascular disease. The objective of this study was to conduct a systematic review and meta-a
Autor:
Yedy P Sukmawan
Publikováno v:
Cardiovascularhematological agents in medicinal chemistry. 16(2)
Background Non-Steroidal Anti Inflammation Drugs (NSAIDs) have shown effectivity in pain relief and are the most prescribed around the world. However, NSAIDs impair hematological aspects that may lead to the life-threatening events. Objective The obj
Publikováno v:
Indonesian Journal of Clinical Pharmacy, Vol 7, Iss 4, Pp 243-251 (2018)
Type 2 Diabetes mellitus (T2DM) is a degenerative disease and approximately 50% of patients with diabetes mellitus (DM) of more than 20 years’ duration also have diabetic nephropathy (DN). T2DM accounts for significant morbidity and mortality, howe